Chargement en cours...
Are aromatase inhibitors associated with higher myocardial infarction risk in breast cancer patients? A Medicare population‐based study
BACKGROUND: Theoretically, the estrogen deprivation induced by aromatase inhibitors (AIs) might cause ischemic heart disease, but empiric studies have shown mixed results. We aimed to compare AIs and tamoxifen with regard to cardiovascular events among older breast cancer patients outside of clinica...
Enregistré dans:
| Publié dans: | Clin Cardiol |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Wiley Periodicals, Inc.
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6344290/ https://ncbi.nlm.nih.gov/pubmed/30443921 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.23114 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|